Filing Flows › BioScience Health Innovations (BHIC) › Q3 2025
BioScience Health Innovations (BHIC) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 27, 2025
BioScience Health Innovations (BHIC) reported revenue of $1.1M for the third quarter 2025 (Q3 2025), +97% from a year earlier and -36% from the quarter before. Operating margin was -0.8%, net loss $9K (0.8% of revenue).
BioScience Health Innovations, Q3 2025: revenue $1.1M (+98% year over year), operating margin -0.8%, net loss $9K, operating cash flow −$340K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -36% | +97% |
| Operating profit | −$9K | -102% | — |
| Net earnings | −$9K | -102% | — |
| Operating cash flow | −$340K | -219% | — |
What changed
Revenue was $1.1M in Q3 2025, up 97% year over year and down 36% from the previous quarter.
Gross margin was 61.7%, down 12.4 points from a year earlier. Operating costs exceeded revenue by $9K, an operating margin of -0.8%. Operating expenses grew 92% against revenue growth of 97%. The quarter ended with a net loss of $9K, after a profit of $458K the previous quarter.
Operating cash flow was −$340K. Working capital and other items used $332K.
Questions
What was BioScience Health Innovations' revenue in the third quarter 2025?
BioScience Health Innovations (BHIC) reported revenue of $1.1M for the third quarter 2025 (Q3 2025), +97% from a year earlier and -36% from the quarter before.
Was BioScience Health Innovations profitable in the third quarter 2025?
Operating loss was $9K (-0.8% of revenue) and net loss $9K.